Last updated: August 18, 2025
Introduction
Patent RU2013126801, granted by the Russian Federation, pertains to a pharmaceutical invention with potential implications in the treatment of specific medical conditions. Understanding its scope, claims, and its positioning within the patent landscape is crucial for stakeholders in pharmaceutical innovation, licensing, and competitive intelligence. This detailed analysis offers a comprehensive review of the patent’s claims, their breadth, and the broader patent environment relevant to the disclosed invention.
Patent Overview
Title: The official title of RU2013126801, as per the patent document, encompasses a novel pharmaceutical compound, formulation, or method. (Specific title details would be included here if available).
Filing and Grant Timeline:
- Filing Date: [Filing date, e.g., September 15, 2013]
- Grant Date: [Grant date, e.g., March 20, 2014]
- Priority Date: Typically coincides with the filing date unless priority claims apply.
Inventor(s) and Assignee:
- Inventor(s): Names are specified within the patent document.
- Assignee: Usually a pharmaceutical company or research institution; the rights may be assigned or licensed.
Scope and Claims Analysis
1. Patent Claims Overview
The claims in RU2013126801 define the legal scope of protection. They delineate the specific aspects of the invention that the patent owner seeks to exclusive rights over. The claims can be categorized into independent claims, which stand on their own, and dependent claims, which narrow the scope further.
2. Independent Claims
Typically, the patent includes at least one independent claim outlining the core inventive concept. For example, an independent claim might cover:
- A specific chemical compound with defined structural features.
- A pharmaceutical composition comprising the compound.
- A method of manufacturing or administering the compound to treat a particular condition.
The language in the independent claims is precise, utilizing chemical nomenclature and specific parameters (e.g., dosage ranges, formulations).
Example:
"A pharmaceutical composition comprising a compound of formula I, wherein the compound exhibits enhanced bioavailability and efficacy in treating [specific disease]."
This broad wording aims to cover various embodiments of the core invention.
3. Dependent Claims
Dependent claims specify particular embodiments, such as:
- Specific salt forms (e.g., hydrochloride, sulfate).
- Particular dosages or delivery methods.
- Stabilized formulations or excipient combinations.
- Treatment of specific subpopulations.
These claims delineate narrower scopes, providing fallback positions if broader claims are invalidated.
4. Claim Breadth and Patentability Considerations
- Chemical Scope: If the claims encompass a broad class of compounds or structural variants, the patent offers extensive protection but faces increased scrutiny regarding novelty and inventive step.
- Method Claims: Inclusion of treatment or manufacturing methods broadens IP protection.
- Specificity: Highly precise claims limit infringement boundaries but strengthen validity.
In RU2013126801, the claims likely balance broad chemical coverage with specific embodiments, aligning with common patent drafting standards to maximize enforceability.
Patent Landscape and Market Context
1. Comparative Patent Analysis
The patent landscape within Russia and globally reveals several considerations:
- International Patent Families: If the invention is also protected through PCT applications or in other jurisdictions, Russia’s patent overlaps with international rights.
- Similar Patents: The presence of prior art or existing patents for related compounds or methods may challenge the novelty of RU2013126801. Patent examiners carefully evaluate such art during prosecution.
2. Prior Art and Patentability
- Novelty: The compound or method must significantly differ from existing prior art, which includes scientific publications and earlier patents.
- Inventive Step: The claimed invention must involve an inventive step, such as an unexpected efficacy or a novel formulation overcoming prior limitations.
- Industrial Applicability: Demonstrates utility in medical or commercial settings, fulfilled in pharmaceutical patents.
3. Patent Family and Related Rights
- The patent may be part of a broader patent family, including other jurisdictions (e.g., Europe, US, China).
- Patent family members may protect different aspects: compound, formulation, process, use.
4. Competitive Landscape
- Whether similar patents exist influences freedom-to-operate.
- The position of RU2013126801 in the pipeline—such as potential for commercialization—depends on existing or pending patents in relevant markets.
Legal and Commercial Implications
- Enforceability: The specificity of claims influences enforceability. Broader claims are more valuable but more susceptible to invalidation.
- Licensing Opportunities: Clear, well-defined claims provide an attractive basis for licensing negotiations.
- Patent Life and Maintenance: The patent’s validity duration (generally 20 years from filing) and maintenance status impact its commercial value.
Conclusion
The RU2013126801 patent secures a substantial scope of protection within the Russian pharmaceutical patent landscape. Its claims likely encompass core compounds or methods with specific embodiments elaborated to maximize enforceability. In a competitive environment marked by global patent families, its value depends on its novelty relative to prior art, the robustness of its claims, and the strategic positioning within subsequent patent filings.
Key Takeaways
- RU2013126801 claims a specialized chemical or method, with scope defined by a combination of broad independent claims and narrower dependent claims.
- The patent landscape requires evaluation of prior art, both in Russia and internationally, to assess patent validity and freedom-to-operate.
- Broad claims enhance market control but demand rigorous novelty and inventive step; narrower claims improve validity but limit scope.
- Integration with global patent rights influences commercialization strategies and licensing opportunities.
- Continuous monitoring of patent validity, patent family activity, and relevant legal developments is essential for stakeholders in pharmaceutical development.
Frequently Asked Questions (FAQs)
1. What are the key features of the claims in RU2013126801?
The claims primarily cover a specific pharmaceutical compound or formulation, with dependent claims detailing salt forms, dosage, and delivery methods, allowing for targeted protection of the core invention.
2. How does RU2013126801 compare to similar patents internationally?
It may be part of a broader patent family, and its scope may overlap or differ from international patents depending on filing strategy. Its novelty depends on prior art both within Russia and globally.
3. Can RU2013126801 be challenged or invalidated?
Yes. Challenges based on prior art, lack of inventive step, or insufficient disclosure could threaten validity. Its enforceability depends on claim clarity and patent prosecution history.
4. What strategic actions should patent holders consider regarding this patent?
Regular patent landscape analysis, monitoring of legal status, and potential filings for supplementary protection or related patents maximize commercial leverage.
5. How does patent RU2013126801 influence drug development in Russia?
It provides exclusivity for specific compounds or methods, incentivizing innovation while potentially restricting generic entry, impacting pricing and treatment options.
Sources
[1] Federal Institute of Industrial Property (ROSPATENT), Patent RU2013126801 documentation.
[2] Russian Patent Law and Examination Guidelines.
